Rapid Quantification of SARS-CoV-2 Neutralising Antibodies Using Time-Resolved Fluorescence Immunoassay
The quantification of neutralising antibodies (NAb) for SARS-CoV-2 has become an important tool for monitoring protective immunity following infection or immunisation. In this study, we evaluated using World-Health-Organisation-standard immunoglobulin preparations, a novel point-of-care test that qu...
Main Authors: | Gary R. McLean, Yueke Zhang, Rene Ndoyi, Adam Martin, Julian Winer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/12/2149 |
Similar Items
-
Rapid quantification of SARS-CoV-2 neutralising antibodies using time- resolved fluorescence immunoassay
by: McLean, Gary R., et al.
Published: (2022) -
Mechanisms of Rhinovirus Neutralisation by Antibodies
by: Lila Touabi, et al.
Published: (2021-02-01) -
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
by: George W. Carnell, et al.
Published: (2023-02-01) -
Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application
by: Alexander Hargreaves, et al.
Published: (2021-09-01) -
Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)
by: Benjamin Meyer, et al.
Published: (2020-01-01)